Results 101 to 110 of about 21,293 (203)

Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results [PDF]

, 2017
Background. Cobicistat (COBI) is a pharmacoenhancer with no antiretroviral activity in vitro. Methods. An international, randomized, double-blind, double-dummy, active-controlled trial was conducted to evaluate the efficacy and safety of COBI versus ...
Andrade-Villanueva, Jaime, Antunes, Francisco, Arastéh, Keikawus, Callebaut, Christian, Cheng, Andrew K., Chetchotisakd, Ploenchan, DeJesus, Edwin, Fehr, Jan, Gallant, Joel E., Koenig, Ellen, Liu, Yapei, Moyle, Graeme, Rhee, Martin S., Rizzardini, Giuliano, Szwarcberg, Javier, Zhong, Lijie   +15 more
core  

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention [PDF]

, 2014
Background: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy for which adherence is a known determinant of efficacy. Blood concentrations of PrEP medications are one objective marker of adherence.
Baeten, Jared M., Bangsberg, David R., Brantley, Justin, Bumpus, Namandjé N., Celum, Connie, Donnell, Deborah, Haberer, Jessica E., Hendrix, Craig, Mugo, Nelly, Mujugira, Andrew, Ndase, Patrick   +10 more
core   +1 more source

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles [PDF]

Clinical and Molecular Hepatology, 2022
Hung-Yao Lin, Tai-Chung Tseng
doaj   +1 more source

Reply to: “Promising Drugs Require Proper Testing”: Let's Not Confuse Pharmacodynamics With Clinical Efficacy

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
Inès Ben Ghezala, Marc Bardou
wiley   +1 more source

The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report

Infection and Drug Resistance, 2021
Jing Li,1 Donghua Zhang,1 Xinxin Zhang1,2 1Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Sino-French Research ...
Li J, Zhang D, Zhang X
doaj  

Promising Drugs Require Proper Testing

Clinical and Translational Science, Volume 19, Issue 5, May 2026.
Jean‐Jacques Parienti
wiley   +1 more source

Low Bone Mineral Density in Men Living with HIV on Tenofovir Antiretroviral Therapy: A Cross-Sectional Exploratory Study from a Malaysian Tertiary Hospital

Tropical Medicine and Infectious Disease
Background and objectives: Low bone mineral density (BMD) is a recognized complication in people living with HIV (PLHIV) that remains under-addressed, particularly in Malaysia.
Muhamad Riduan Daud, Petrick Periyasamy, Kok-Yong Chin, Najma Kori, Ummu Afeera Zainulabid, Sheng Qian Yew, Nur Ezzaty Mohammad Kazmin, Xiong Khee Cheong   +7 more
doaj   +1 more source

The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study. [PDF]

, 2020
BACKGROUND:Understanding factors driving virological failure, including the contribution of HIV drug resistance mutations (DRM), is critical to ensuring HIV treatment remains effective.
Barnhart, Scott, Gilmore, Hailey J, Grignon, Jessica S, Hunt, Gillian, Liegler, Teri, Lippman, Sheri A, Mooney, Alyssa C, Prach, Lisa M, Puren, Adrian, Truong, Hong-Ha M   +9 more
core  

HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania

Kidney Medicine
Rationale & Objective: Longitudinal research on chronic kidney disease (CKD) in sub-Saharan Africa is sparse, especially among people living with HIV (PLWH).
Nicholas L.S. Roberts, Salama Fadhil, Megan Willkens, Grace Ruselu, Bernard Desderius, Said Kanenda, Ladius Rudovick, Bazil B. Kavishe, Serena P. Koenig, Sri Lekha Tummalapalli, Myung Hee Lee, Robert N. Peck   +11 more
doaj   +1 more source

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs [PDF]

, 2017
Objectives: HIV-1 subtype C might have a greater propensity to develop K65R mutations in patients with virological failure compared with other subtypes. However, the strong association between viral subtype and confounding factors such as exposure groups
Churchill, D, Clark, D, Collins, S, Dunn, DT, Jose, S, Nelson, M, Pillay, D, Sabin, C, Smit, E, Tostevin, A, UK HIV Drug Resistance Database and the UK Collaborative HIV Coh, ., White, E, Winston, A, Zhang, H   +13 more
core